Clinical Trial

Infectious Complications After Cystectomy: A Prospective Observational Study

Recruiting

Record status

This record was last updated September 19, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.

Summary

Patients undergoing cystectomy for either oncological or non-oncological indications are prospectively enrolled following informed consent. This study design incorporates a comprehensive medical history, detailed prospective documentation of clinicopathological parameters, and serial measurements of infectious markers pre- and post-operatively. In-hospital complications are meticulously recorded, and long-term outcomes assessed through structured follow-up interviews at 3, 6, and 12 months. These follow-ups utilize standardized questionnaires to evaluate post-discharge infectious complications and gather patients' perspectives on their in-hospital experiences, providing a robust understanding of both clinical outcomes and patient-reported experiences.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2021-11-29.

Trial Details

NCT Number	NCT05153694
Lead Sponsor	Ludwig-Maximilians - University of Munich
Conditions	Bladder Cancer, Infections, Infection, Bacterial, Infection, Hospital, Infection Wound, Urinary Tract Infections, Urinary Bladder Diseases, Urinary Tract Disease
Enrollment	200 participants
Start Date	2021-12-01
Primary Completion	2024-12-31 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-09-19